Home > News > Asensio Announces Investment Opinion on NVE
April 2nd, 2004
Asensio Announces Investment Opinion on NVE
Today Asensio & Company, Inc., with 12 years of experience as a leading independent equity research firm, published two research reports on NVE Corporation (NASDAQ Symbol: NVEC, $50.83) titled "NVEC fails to solve Cypress' MRAM problems" and "Cypress values NVEC at a maximum of $4.85 per share."
Elsevier Business Intelligence (EBI) to Host 'IN3 Medical Device 360 Boston,' June 24-26, 2013 May 20th, 2013
Aspen Aerogels Announces $22.5 Million Private Placement May 18th, 2013
Harris & Harris Group Notes the Sale of a Second D-Wave Quantum Computer May 16th, 2013
Nanometrics Announces Upcoming Investor Events May 14th, 2013